224 related articles for article (PubMed ID: 27810652)
1. Alcohol use and hepatitis C virus treatment outcomes among patients receiving direct antiviral agents.
Tsui JI; Williams EC; Green PK; Berry K; Su F; Ioannou GN
Drug Alcohol Depend; 2016 Dec; 169():101-109. PubMed ID: 27810652
[TBL] [Abstract][Full Text] [Related]
2. Effect of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir and Ledipasvir/Sofosbuvir Regimens on Survival Compared With Untreated Hepatitis C Virus-Infected Persons: Results From ERCHIVES.
Butt AA; Yan P; Simon TG; Abou-Samra AB
Clin Infect Dis; 2017 Sep; 65(6):1006-1011. PubMed ID: 28903508
[TBL] [Abstract][Full Text] [Related]
3. Real-world effectiveness and predictors of sustained virological response with all-oral therapy in 21,242 hepatitis C genotype-1 patients.
Backus LI; Belperio PS; Shahoumian TA; Loomis TP; Mole LA
Antivir Ther; 2017; 22(6):481-493. PubMed ID: 27934775
[TBL] [Abstract][Full Text] [Related]
4. Changes in Alcohol Consumption following Direct-Acting Antiviral Treatment for Hepatitis C in VA Patients with Comorbid Alcohol Use Disorder and PTSD.
Hoyt JE; Teja N; Jiang T; Rozema L; Gui J; Watts BV; Shiner B; Gradus JL
J Dual Diagn; 2022; 18(4):185-198. PubMed ID: 36151743
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hepatitis C virus recurrence after transplantation with sofosbuvir/ledipasvir: The role of ribavirin.
Globke B; Raschzok N; Teegen EM; Pratschke J; Schott E; Eurich D
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943544
[TBL] [Abstract][Full Text] [Related]
6. Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy.
Cartwright EJ; Pierret C; Minassian C; Esserman DA; Tate JP; Goetz MB; Bhattacharya D; Fiellin DA; Justice AC; Lo Re V; Rentsch CT
JAMA Netw Open; 2023 Sep; 6(9):e2335715. PubMed ID: 37751206
[TBL] [Abstract][Full Text] [Related]
7. Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV genotype 1 infected persons: results from ERCHIVES.
Butt AA; Yan P; Marks K; Shaikh OS; Sherman KE;
Aliment Pharmacol Ther; 2016 Oct; 44(7):728-37. PubMed ID: 27459341
[TBL] [Abstract][Full Text] [Related]
8. Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17 487 patients.
Su F; Beste LA; Green PK; Berry K; Ioannou GN
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):686-693. PubMed ID: 28195877
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of hepatitis C antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma.
Beste LA; Green PK; Berry K; Kogut MJ; Allison SK; Ioannou GN
J Hepatol; 2017 Jul; 67(1):32-39. PubMed ID: 28267622
[TBL] [Abstract][Full Text] [Related]
10. The association between race/ethnicity and the effectiveness of direct antiviral agents for hepatitis C virus infection.
Su F; Green PK; Berry K; Ioannou GN
Hepatology; 2017 Feb; 65(2):426-438. PubMed ID: 27775854
[TBL] [Abstract][Full Text] [Related]
11. Transformation of hepatitis C antiviral treatment in a national healthcare system following the introduction of direct antiviral agents.
Moon AM; Green PK; Berry K; Ioannou GN
Aliment Pharmacol Ther; 2017 May; 45(9):1201-1212. PubMed ID: 28271521
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotypes 1-4 and 6 in Myanmar: Real-world experience.
Hlaing NKT; Mitrani RA; Aung ST; Phyo WW; Serper M; Kyaw AMM; Bwa AH; Win KM; Reddy KR
J Viral Hepat; 2017 Nov; 24(11):927-935. PubMed ID: 28475232
[TBL] [Abstract][Full Text] [Related]
13. Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment.
Haque LY; Fiellin DA; Tate JP; Esserman D; Bhattacharya D; Butt AA; Crystal S; Edelman EJ; Gordon AJ; Lim JK; Tetrault JM; Williams EC; Bryant K; Cartwright EJ; Rentsch CT; Justice AC; Lo Re V; McGinnis KA
JAMA Netw Open; 2022 Dec; 5(12):e2246604. PubMed ID: 36515952
[TBL] [Abstract][Full Text] [Related]
14. Dramatic response of hepatitis C patients chronically infected with hepatitis C virus genotype 3 to sofosbuvir-based therapies in Punjab, Pakistan: A prospective study.
Iqbal S; Yousuf MH; Yousaf MI
World J Gastroenterol; 2017 Nov; 23(44):7899-7905. PubMed ID: 29209131
[TBL] [Abstract][Full Text] [Related]
15. Advanced liver fibrosis effects on the response to sofosbuvir-based antiviral therapies for chronic hepatitis C.
Morio K; Imamura M; Kawakami Y; Nakamura Y; Hatooka M; Morio R; Fujino H; Nakahara T; Murakami E; Kawaoka T; Tsuge M; Hiramatsu A; Aikata H; Hayes CN; Miki D; Ochi H; Katamura Y; Arataki K; Moriya T; Ito H; Tsuji K; Kohno H; Waki K; Tamura T; Nakamura T; Chayama K;
J Med Virol; 2018 Dec; 90(12):1834-1840. PubMed ID: 30016555
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation.
Ciesek S; Proske V; Otto B; Pischke S; Costa R; Lüthgehetmann M; Polywka S; Klempnauer J; Nashan B; Manns MP; von Hahn T; Lohse AW; Wedemeyer H; Mix H; Sterneck M
Transpl Infect Dis; 2016 Jun; 18(3):326-32. PubMed ID: 26988272
[TBL] [Abstract][Full Text] [Related]
17. Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES.
Butt AA; Yan P; Shaikh OS; Chung RT; Sherman KE;
Liver Int; 2016 Sep; 36(9):1275-83. PubMed ID: 26928927
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of sofosbuvir-based regimens in genotype 1 and 2 hepatitis C virus infection in 4026 U.S. Veterans.
Backus LI; Belperio PS; Shahoumian TA; Loomis TP; Mole LA
Aliment Pharmacol Ther; 2015 Sep; 42(5):559-73. PubMed ID: 26113432
[TBL] [Abstract][Full Text] [Related]
19. Implications of HCV RNA level at week 4 of direct antiviral treatments for hepatitis C.
Johnson K; Green PK; Ioannou GN
J Viral Hepat; 2017 Nov; 24(11):966-975. PubMed ID: 28585416
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists.
Deming P; Martin MT; Chan J; Dilworth TJ; El-Lababidi R; Love BL; Mohammad RA; Nguyen A; Spooner LM; Wortman SB
Pharmacotherapy; 2016 Feb; 36(2):203-17. PubMed ID: 26846728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
